Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records) |
Query Trace: Lymphoma and CCND1[original query] |
---|
Cyclin D1 splice variant and risk for non-Hodgkin lymphoma. Human genetics 2006 Sep 120 (2): 297-300. Wang Sophia S, Cozen Wendy, Severson Richard K, Hartge Patricia, Cerhan James R, Davis Scott, Welch Robert, Rothman Nathaniel, Chanock Stephen |
Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Apr 18 (4): 1259-70. Morton Lindsay M, Purdue Mark P, Zheng Tongzhang, Wang Sophia S, Armstrong Bruce, Zhang Yawei, Menashe Idan, Chatterjee Nilanjan, Davis Scott, Lan Qing, Vajdic Claire M, Severson Richard K, Holford Theodore R, Kricker Anne, Cerhan James R, Leaderer Brian, Grulich Andrew, Yeager Meredith, Cozen Wendy, Hoar Zahm Shelia, Chanock Stephen J, Rothman Nathaniel, Hartge Patric |
Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma. Cancer causes & control : CCC 2010 May 21 (5): 759-69. Fernberg Pia, Chang Ellen T, Duvefelt Kristina, Hjalgrim Henrik, Eloranta Sandra, Sørensen Karina Meden, Porwit Anna, Humphreys Keith, Melbye Mads, Ekström Smedby Kar |
The CCND1 G870A gene polymorphism and leukemia or non-Hodgkin lymphoma risk: a meta-analysis. Asian Pacific journal of cancer prevention : APJCP 2014 15 (16): 6923-8. Qin Ling-Yan, Zhao Li-Gang, Chen Xu, Yang Zheng, Mo Wu-Ni |
MYC rearranged B-cell neoplasms: Impact of genetics on classification. Cancer genetics 2016 Oct 209 (10): 431-439. Haberl Sabine, Haferlach Torsten, Stengel Anna, Jeromin Sabine, Kern Wolfgang, Haferlach Claud |
Genomic landscape and prognostic analysis of mantle cell lymphoma. Cancer gene therapy 2018 May . Yang Ping, Zhang Weilong, Wang Jing, Liu Yuanyuan, An Ran, Jing Hongm |
Aggressive morphologic variants of mantle cell lymphoma characterized with high genomic instability showing frequent chromothripsis, CDKN2A/B loss, and TP53 mutations: A multi-institutional study. Genes, chromosomes & cancer 2020 4 59 (8): 484-494. Streich Lukas, Sukhanova Madina, Lu Xinyan, Chen Yi-Hua, Venkataraman Girish, Mathews Stephanie, Zhang Shanxiang, Kelemen Katalin, Segal Jeremy, Gao Juehua, Gordon Leo, Chen Qing, Behdad Am |
NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment. Molecular oncology 2021 May . Sánchez-Herrero Estela, Serna-Blasco Roberto, Ivanchuk Vadym, García-Campelo Rosario, Dómine Gómez Manuel, Sánchez José M, Massutí Bartomeu, Reguart Noemi, Camps Carlos, Sanz-Moreno Sandra, Calabuig-Fariñas Silvia, Jantus-Lewintre Eloísa, Arnal Magdalena, Fernández-Orth Dietmar, Calvo Virginia, González-Rumayor Víctor, Provencio Mariano, Romero Atoc |
Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma. Oncotarget 2022 9 13 986-1002. LeBlanc Francis R, Hasanali Zainul S, Stuart August, Shimko Sara, Sharma Kamal, Leshchenko Violetta V, Parekh Samir, Fu Haiqing, Zhang Ya, Martin Melvenia M, Kester Mark, Fox Todd, Liao Jiangang, Loughran Thomas P, Evans Juanita, Pu Jeffrey J, Spurgeon Stephen E, Aladjem Mirit I, Epner Elliot |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: